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Abstract:  With  an  optical  fiber  probe,  we  acquired  spectra  from  swine 
tissue between 500 and 1600 nm by combining a silicon and an InGaAs 
spectrometer.  The  concentrations  of  the  biological  chromophores  were 
estimated by fitting a mathematical model derived from diffusion theory. 
The  advantage  of  our  technique  relative  to  those  presented  in  previous 
studies is that we extended the commonly-used wavelength ranges of 500 
and 1000 nm to include the range of 1000 to 1600 nm, where additional 
water and lipid absorption features exist. Hence, a more accurate estimation 
of these two chromophores is expected when spectra are fitted between 500 
and 1600 nm than between 500 and 1000 nm. When extending the UV-VIS 
wavelength range, the estimated total amount of chromophores approached 
100% of the total as present in the probed volume. The confidence levels of 
the water and lipid related parameters increases by a factor of four. 
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OCIS  codes:  (170.6935)  Tissue  characterization;  (300.6170)  Spectra;  (170.3660)  Light 
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1. Introduction 
Diffuse optical spectroscopy (DOS) has been widely used as a tool for determining optical 
properties of tissue. Such tools are investigated as an aid for  detecting cancers [1–4], for 
monitoring changes in tissue optical properties that reflect morphological and physiological 
changes [5], and for monitoring therapy response for instance in photodynamic therapy [6]. 
Several methods exist to extract optical properties of tissue-like diffuse media such as time-
resolved [7,8], frequency-domain [9], spatially-resolved continuous wave [10,11], combined 
frequency-domain  and  continuous  wave  broadband  diffuse  optical  spectroscopy  [3],  and 
empirical models based on Monte-Carlo simulations and experimental phantoms of known 
optical properties [5,12,13]. 
#135273 - $15.00 USD Received 17 Sep 2010; revised 28 Oct 2010; accepted 16 Nov 2010; published 17 Nov 2010
(C) 2010 OSA 22 November 2010 / Vol. 18,  No. 24 / OPTICS EXPRESS  1433Most of the studies [2,14–19] focused on the estimation of chromophore concentrations in 
the  ultraviolet  and  visible  wavelength  range  (typically  between  350  and  800  nm)  where 
deoxygenated and oxygenated hemoglobin are the main optical absorbers. Measurements in 
breast [2,14,15] or on the skin [16] showed absorption from additional chromophores such as 
beta-carotene and melanin, respectively. Several studies used wavelength ranges extended up 
to 1000 nm [3,17,18] in order to determine concentrations of water and lipid, which have 
distinct absorption peaks at 972 and 930 nm, respectively [18,19]. These studies [3,17–19] 
used probes with fiber separations up to 1.7 cm. For probes with much shorter separation 
between the collecting and emitting fibers, the absorption dips in the reflectance due to lipid 
and water will also be much smaller since the transmitted light decays exponentially with the 
path length and the absorption coefficient (Beer‟s law). Thus, measurements of water and 
lipid content in this wavelength region using photon pathlengths of a few mm only will not be 
very accurate. Extending the commonly used wavelength range of 500 to 1000 nm up to 1600 
nm enables the measurement of additional absorption peaks of water and lipid with absorption 
values  that  are  an  order of  magnitude higher  than  those  in  the  lower  wavelength  region. 
Although not extensively reported, not constraining the fitting parameters [17] often leads to 
an estimated summed volume of chromophores significantly different from a total of 100%. 
This could either mean that there is a biological entity within the probed volume that does not 
have optical absorption peaks (e.g. melanin) or that the model requires modifications. The 
present paper aims to investigate if the use of this extended wavelength region increases the 
accuracy of the measurement without constraining any of the fit parameters. 
The applicability of an analytical solution that derives from diffusion theory to determine 
the  optical  properties  was  extensively  studied  and validated  for  wavelength  ranges below 
1000  nm  [10,11].  In  a  former  study  [20],  the  absorption  coefficients  of  water  and  lipid 
between 900 and 1600 nm (I9001600) were measured and the applicability of the diffusion 
theory model to this wavelength range was validated for phantom measurements with known 
amounts of water and lipid. 
To investigate whether having an additional spectrometer that can measure in the infrared 
up to 1600 nm can effectively improve the estimation of water and lipid concentrations, we 
compared  the  values  of  the  parameters  derived  from  the  fits  applied  for  two  different 
wavelength ranges: the classical range from 500 to 1000 nm (I5001000) and the extended range 
from 500 to 1600 nm (I5001600). Measurements on in vivo swine tissues were performed with 
combined silicon and InGaAs spectrometers and were analyzed by fitting an analytical model 
to the two wavelength ranges of interest. In order to assess the improvements to the fits when 
adding the InGaAs spectrometer, we compared the confidence intervals [21] of the estimated 
parameters obtained from both fits. 
2. Methods 
2.1 Instrumentation 
A schematic diagram of the setup is shown in Fig. 1. The setup consists of an optical probe 
with three optical fibers with a NA of 0.22, a spectrometer with a silicon detector (Andor 
Technology, DU420A-BRDD), a spectrometer with an InGaAs detector (Andor Technology, 
DU492A-1.7)  and  a  tungsten  halogen  broadband  light  source  with  an  integrated  shutter 
(Ocean Optics, HL-2000-HP). The optical probe has a diameter of 1.3 mm and its distal end is 
polished at an angle of 20 degrees in order to ease its insertion in the animals. The probe 
contains three 200 μm core diameter optical fibers with axis of symmetry parallel to the axis 
of symmetry of the probe. One optical fiber is connected to a light source. The second and 
third  optical  fibers  are  connected  to  the  spectrometer  with  a  silicon  detector  and  the 
spectrometer with an InGaAs detector, respectively. The silicon detector is a matrix of 1024 
by 255 pixels with pixel size of 26x26 microns whereas the InGaAs detector is a single array 
of 512 pixels with a pixel size of 500x50 microns. The spectral resolution for the silicon and 
InGaAs detectors are 4 and 10 nm, respectively. At the tip of the probe, the three optical fibers 
distal ends form an isosceles triangle in such a way that both collecting fibers were embedded 
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2.48 mm from the emitting fiber. 
 
Fig. 1. Sketch of the optical setup: it consists of a halogen lamp that is connected to a fiber and 
two spectrometers that are connected to two separate fibers that are located next to each other 
at the tip of the probe. 
2.2 Data acquisition and pre-processing 
The calibration and the generation of the spectra acquired with the InGaAs spectrometer was 
described  elsewhere  [20].  Briefly,  the  calibration  procedure  consisted  of  assigning  a 
wavelength value to each pixel of the detector, then measuring a white reflectance standard to 
compensate  for  the  spectral  shape  of  the  light  emitted  by  the  lamp  and  the  wavelength-
dependant  sensitivity  of  the  detector  and  the  optics  in  the  grating  of  the  system;  and  a 
background  measurement  to  compensate  for  the  dark  current  and  electric  offsets  of  the 
detector. The tissue spectra are computed by dividing the measured spectra in tissue corrected 
for background by the calibration measurement of the white reflectance standard. We applied 
the same process for the spectra acquired with the silicon spectrometer. The spectra obtained 
from both spectrometers have an overlapping wavelength range between 900 and 1000 nm 
which was used to compute the matching factor to form continuous spectra from 500 and 
1600 nm. For all the acquired spectra, the matching factor should be ideally equal to one but is 
on average 0.9 ± 0.3. This is due to the fact that the light is collected via two separate fibers 
and in an inhomogeneous medium there might be a sampling error. To avoid this artifact, one 
single fiber should be connected to a fiber splitter in order to collect the light from the same 
sampling volume. However, using a fiber splitter will reduce the light transmission by more 
than 50% and thus longer integration times might be needed to achieve a good signal-to-noise 
ratio making real-time feedback impossible. 
2.3 Tissue measurements 
Measurements were performed on three anaesthetized swine after approval from the internal 
review board of the animal lab facility. The swine were originally dedicated for a different 
clinical study; however we were allowed to perform our measurements. Spectra were taken at 
different locations within the animals, where the position of the tip of the optical probe was 
confirmed  by  X-ray  or  ultrasound  imaging.  Tissue  boundaries  were  avoided  in  order  to 
measure in volumes as homogenous as possible. 
The integration time for a single spectrum acquisition ranges from a quarter of a second to 
two seconds but most spectra were acquired with an integration time of one second yielding to 
a signal-to-noise ratio of 200:1 and 120:1 for the Silicon and InGaAs detector, respectively. 
However, all measurements on the white reflectance standard for calibration were made with 
an integration time of two seconds. For both spectrometers, the integration time was kept the 
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structures (from which 56 subcutaneous fat in the back of the pig and 87 visceral fat in the 
epidural space) and 153 muscle measurements in the back of the three animals. 
2.4 Analytical model 
The acquired spectra were fitted with the analytical model developed by Farrell et al. [10] 
which has the absorption coefficient    a   and the reduced scattering coefficient  
,
s  , in 
cm
1, as input arguments. In a previous work [20], this model was described and used to 
estimate  water  and  lipid  concentration  and  its  validity  was  shown  in  the  900-1600  nm 
wavelength range. 
A double power law function was used to describe the wavelength dependence of the 
reduced scattering (cf. Equation (1)). The first law corresponds to the contribution of Mie 
scattering [22–24] whereas the second power law corresponds to the contribution of Rayleigh 
scattering  which  can  be  significant  in  the  visible  wavelength  range  [25].  The  reduced 
scattering is expressed in cm
1 and is a function of wavelength: 






s MR MR a

   

     
             
   (1) 
In Eq. (1),  0  is a normalization wavelength set to 800 nm and the parameter  a corresponds to 
the  reduced  scattering  amplitude  at  this  specific  wavelength.  The  reduced  scattering 
corresponds to the sum of Mie and Rayleigh scattering and, therefore,  MR   is defined as the 
Mie-to-Rayleigh fraction of the scattering. The reduced scattering slope of the Mie scattering 
is denoted b  and is related to the particle size [26]. 
The  main  chromophores  that  absorb  in  the  visible  and  near  infrared  are  hemoglobin 
derivatives in the blood (deoxy-hemoglobin and oxy-hemoglobin) [27,28], water and lipid 
[18,20,29]. Instead of modeling the absorption coefficient    a   as the sum of absorption 
coefficients weighted by the respective concentrations of the four chromophores of interest, 
we decided to express the absorption coefficient as: 
                1.
Blood Water Lipid
a BL a WL WL a WL a C                    (2) 
The  absorption  coefficients  of  hemoglobin  in  blood,  water  and  lipid  are   
Blood
a  , 
 
Water
a   and   
Lipid
a  , respectively; and are depicted in Fig. 2. The absorption coefficient 
of blood is multiplied by the blood volume fraction      2 BL Hb HbO   , where    Hb  and 
  2 HbO   correspond  to  the  concentration  of  deoxygenated  and  oxygenated  hemoglobin, 
respectively; and a correction factor    C   that accounts for the effect of pigment packaging 
[30] and alters for the shape of the absorption spectrum. The correction factor is given by 
   















    (3) 
where  R  corresponds to the effective vessel radius. The absorption coefficient of hemoglobin 
in blood is given by 
         
2 1.
HbO Blood Hb
a BL a BL a               (4) 
Here   
2 HbO
a    and   
Hb
a    represent  the  basics  extinction  coefficient  spectra  of 
oxygenated  and  deoxygenated  hemoglobin,  respectively,  assuming  a  blood  hemoglobin 
content of 150 g/l (typical value for human blood). The oxygenated hemoglobin fraction in the 
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as  the  blood  oxygen  saturation.  Similarly      2 WL H O Lipid     and 
        2 WL Lipid Lipid H O    where   Lipid  and   2 HO correspond to the concentration 
of lipid (density of 0.86g/ml) and water, respectively. They correspond to the total amount of 
water and lipid in the probed volume and the lipid fraction within this volume, respectively. 
This  way  of  relating  the  water  and  lipid  parameters  in  the  expression  of  the  absorption 
coefficient defined in Eq. (2) rather than estimating separately the water and lipid volume 
fraction corresponds to a minimization of the covariance of the basis functions for fitting 
resulting in a more stable fit. 
 
Fig. 2. Absorption coefficient of deoxygenated hemoglobin (full line), oxygenated hemoglobin 
(dashed line), water (dotted line) and lipid (dashed-dotted line) from 500 to 1600 nm. 
From the acquired spectra we derive eight parameters:  a ,  b ,  MR  ,  R ,  BL  ,  BL  ,  WL   
and WL  .  Hence  three  parameters  define  the  reduced  scattering  coefficient,  and  five 
components the absorption coefficient, from which three are related to blood and the two 
other  to  water  and  lipid.  Although  not  commonly  used  when  fitting  beyond  500  nm,  a 
Rayleigh scattering term and the correction factor for pigment packaging were used [17]. 
According to an F-test with p<0.001 [31], the fit is improved for 64% and 89% of the data 
when  considering  Rayleigh  scattering  and  the  pigment  packaging  factor  in  the  model, 
respectively. The spectra were fitted over the 500-1000 nm and 500-1600 nm wavelength 
ranges  using  a  non  constrained  nonlinear  least-squares  Levenberg-Marquardt  fitting 
algorithm. The confidence intervals on the estimated parameters at a confidence level of 99% 
were assessed from the square roots of the diagonal elements of the covariance matrix [21]. 
A  detailed  study  on  the  validation  and  calibration  of  the  model  in  the  900-1600  nm 
wavelength  range  was  described  in  Ref.  20  based  on  phantom  experiments.  Given  the 
extensive literature descriptions of the model validation in the 500-1000 nm wavelength range 
[10,11], only a validation comparable to the one in Ref. 10 was performed to make sure that 
the model estimates the correct blood volume faction with our setup. A set of phantoms that 
consist of human blood diluted in a scattering solution (80 mg of oil-free scattering powder in 
PBS) were prepared to obtain blood volume fractions of 0.5, 1, 5 and 10% of a total phantom 
volume of 10 ml for each dilution. As soon as the blood was extracted from the subject, a 
blood oxygen saturation of 98.9% was measured with a blood gas analyzer (RapidPoint 405) 
before  the  preparation  of  the  phantoms.  When  comparing  the  estimated  blood  volume 
fractions with the actual values, a linear regression of equation y = 0.97x-0.01 was obtained 
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2 = 0.993). A blood oxygen saturation of 96.1 ± 2.3% was estimated which is in good 
agreement with the value estimated by the blood gas analyzer. 
3. Results and discussion 
Figure  3  shows  typical  diffuse  optical  spectra  measured  on  a  muscle  and  a  fat  layer 
respectively with the corresponding fit over I5001600. Moreover, it also shows the residual. 
 
Fig. 3. Typical measurement of muscle and fat layer (dotted line), and the corresponding fits 
and residuals between 500 and 1600 nm (full line). 
When measuring with a silicon spectrometer, it is possible to estimate the amount of water 
and lipid due to the absorption peaks of these two chromophores that exist in the 900 to 1000 
nm wavelength range. However it is interesting to investigate whether any advantages arise 
from adding an InGaAs spectrometer to accurately estimate the amount of water and lipid. 
Table 1 summarizes the average values that are estimated from fitting at I5001000 (Fit 1) and 
I5001600 (Fit 2) and their respective average confidence intervals. It is clear from Table 1 that 
the total amount of chromophores (i.e.  BL   +  WL  ) is closer to 100% when the fit is applied 
over I5001600. As a matter of comparison, there is a significant difference (t-test, p<0.05) from 
a 100% total amount of chromophores for 67% of the spectra fitted over I5001000 and only 
28% when fitted over I5001600. 
Among the 28% of the spectra for which the total amount of chromophores is statistically 
different from 100%, a few spectra gave numbers statistically higher than 100% when fitting 
between 500 and 1600 nm. A number of effects might be the cause of this. The temperature of 
the animals decreased during the measurement sessions thus the water temperature in the body 
decreased. Therefore, the absorption coefficient of water which is temperature dependant need 
to be adapted in the fitting [20]. Moreover the type of lipid that is used in the fit is from beef 
fat and not from swine. As lipid is composed of different types of fat such as unsaturated, 
monosaturated and polysaturated fat; the beef fat can be chemically different from swine fat. 
This difference in fat provides differences in absorption coefficient of lipid [20]. As it can be 
seen in the residual curve of the fat layer measurement in Fig. 3, the largest deviations are 
around 1100 and 1200 nm where the main difference in absorption values of fat exists as 
presented in Fig. 8 of reference [20]. 
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intervals for fat layers and muscle as derived from fitting over I5001000 (Fit 1) and I5001600 
(Fit 2) 
   Fat layers (n = 143)     Muscle (n = 153) 









1)  5.2 ± 1.7  6.3 ± 0.7 
  
4.0 ± 1.0  4.6 ± 0.4 
b   0.7 ± 0.3  0.8 ± 0.1 
  
0.7 ± 0.3  0.6 ± 0.1 
MR   (%)  98 ± 8  98 ± 6 
  
93 ± 10  87 ± 6 
R  (μm)  23 ± 9  15 ± 5 
  
27 ± 8  19 ± 4 
BL   (%)
(*)  1.0 ± 0.3  0.8 ± 0.1 
  
2.4 ± 0.6  2.0 ± 0.2 
BL   (%)  21 ± 5  21 ± 7 
  
27 ± 5  25 ± 5 
WL   (%)
(*)  112 ± 30  95 ± 5 
  
114 ± 42  89 ± 5 
WL   (%)  60 ± 5  68 ± 1 
  
10 ± 13  18 ± 3 
(*)Significant difference from 100% of the sum with p<0.05 for 67% of all the spectra when 
Fit 1 is applied and 28% of the spectra when Fit 2 is applied. 
Figure 4 compares for each single spectrum the total volume fraction of water and lipid for 
both wavelength ranges. The solid and dashed lines correspond to the mean and standard 
deviation. It is clear from Fig. 4 that fitting the measurement data between 500 and 1600 nm 
reduces  the  standard  deviation  of  the  data  by  a  factor  of  four  compared  to  the  smaller 
wavelength  range.  Moreover,  Table  1  clearly  shows  an  improvement  on  the  confidence 
interval for the estimation of the total amount of water and lipid volume fraction and for the 
lipid fraction within this total volume. 
 
Fig. 4. Estimated water and lipid volume fraction (dots) when fitting between 500 and 1000 nm 
versus 500 and 1000 nm and the respective mean and standard deviation. 
Figure 5 shows in a log-log scale for each of the parameters BL  ,  BL  ,  WL   and  WL   the 
comparison of the confidence intervals for the two wavelength ranges of interest. Computing 
the average of the ratio of the confidence intervals obtained for both fits shows that extending 
the wavelength range up to 1600 nm narrows the confidence intervals of the water and lipid 
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factor of two whereas no improvements are seen for the blood saturation levels. 
 
Fig. 5. Comparison of confidence intervals obtained when fit is applied between 500 and 1000 
nm and 500 and 1600 nm of the blood volume fraction (stars), blood saturation (circles), water 
and lipid volume fraction (crosses) and lipid fraction in the total volume (squares). 
A Spearman‟s rank correlation test [17] is performed to assess the correlation between the 
values  obtained  for  the  two  different  wavelength  ranges.  Such  a  test  determines  whether 
strong  correlation  exists  between  the  estimated  parameters  for  both  wavelength  ranges. 
However, there could be high correlation despite a different dispersion (statistical variability) 
of the values and therefore a statistical test is required to determine whether the standard 
deviations of the estimated values are of the same order for both fits. The Levene‟s test [32] 
was applied to investigate whether there are significant differences between the dispersion of 
the estimated parameters from both fits. Table 2 provides the Spearman‟s rank correlation 
coefficient for each parameter and indicates which parameters have significant differences 
with respect to the values and the dispersion of the values based on the analysis of variance 
and Levene‟s tests. The confidence intervals of the Spearman‟s correlation coefficients were 
computed by using a Fisher‟s z-transformation [32] with p<0.05. From Table 2, it is clear that 
adding the 900-1600 nm data induces statistical differences for  WL   and  WL  . One can notice 
that the lipid fraction parameter is the only parameter that does show significant difference in 
values but not in dispersion. As seen in Table 1, the lipid fraction estimated over I5001000 is 
smaller than when fitting over I5001600. However the values do vary between 0 and 100% and 
therefore there is a non-significant difference in the dispersion of the estimated value for this 
parameter. From Table 2, the Spearman‟s correlation factors are considered to be high (above 
0.8) except for the scattering related parameter and the water and lipid volume fraction. 
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show significant differences in value and dispersion 
Parameters  Spearman‟s correlation 
factor of the 
estimated values 
Significant difference of the 
estimated parameters values 
with p<0.05 for the analysis 
of variance test 
Significant difference of the 
dispersion of the estimated 
parameters with p<0.05 for 
the Levene‟s test 
a  (cm
1)
  0.75 ± 0.05   +   + 
b   0.22 ± 0.10  -  - 
MR   (%)
  0.55 ± 0.08   +   + 
R  (μm)  0.82 ± 0.03  -  - 
BL   (%)  0.81 ± 0.04  -  - 
BL   (%)  0.87 ± 0.02  -  - 
WL   (%)  0.50 ± 0.09   +   + 
WL   (%)  0.90 ± 0.02   +  - 
Although there is a significant difference in the reduced scattering amplitude values  a  for 
both fits, their correlation factor is only as high as 0.75 and not more. It is thus interesting to 
know the cause of this effect. For this purpose, a t-test was performed for all the estimated 
values  of  reduced  scattering  to  know  which  data  points  give  significant  differences  with 
p<0.05. Figure 6.a. depicts the data points for which there is no significant difference in the 
estimated reduced scattering amplitude values for both fits (blue stars) and those for which 
there is difference (red diamonds) according to the t-test. From Fig. 6.a, it can be seen that the 
values  which  are  different  all  have  low  reduced  scattering  amplitudes.  By  plotting  the 
corresponding  water  and  lipid  volume  fractions  that  were  estimated  (cf.  Figure  6.b.),  we 
observe that the values that show significant differences in the reduced scattering amplitudes 
mainly corresponds to the spectra for which  WL   was estimated to be larger than 100% when 
the fit is applied between 500 and 1000 nm. When fitting up to 1600 nm, the estimated  WL   
for  these spectra approaches 100%  and  the reduced  scattering amplitude becomes higher. 
Thus when the reduced scattering amplitude of the measured tissues is low (i.e. smaller than 
the inverse of the fiber distance separation of 5cm
1), its covariance with  WL   is high which 
leads to an incorrect estimation of the latter parameter. Besides, a change in the estimated 
reduced scattering amplitudes also induces a change in the estimation of the blood volume 
fraction (cf. Figure 6.c.). The amount of blood is overestimated when fitting over the 500 to 
1000 nm wavelength range in case of low reduced scattering samples. Otherwise, the blood 
volume fraction values are not altered whilst the amount of water and lipid volume fraction is 
improved. 
By fitting up to 1600 nm where additional absorption features of water and lipid exist, the 
covariance with the reduced scattering as defined in Eq. (1) is smaller and still allows for a 
reliable fit when the reduced scattering coefficient is low. In case the fit is performed between 
500  and  1000  nm,  for  small  reduced  scattering  values,  the  scattering  is  underestimated 
whereas the absorption due to water, lipid and blood is overestimated. 
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Fig. 6. Comparison of the estimated reduced scattering amplitude when fit is applied between 
500 and 1000 nm (Fit 1) and 500 and 1600 nm (Fit 2) where the circles correspond to no 
statistical  difference in  absolute values  and  the  crosses  with  statistical  differences  (a).  The 
corresponding water and lipid volume fractions shows larger deviation from 100% when Fit 1 
is applied (b). The corresponding blood volume fraction shows overestimations of the values 
when Fit 1 is applied (c). 
4. Conclusion 
We have presented a comparison on the estimation of the absorption and reduced scattering 
related  parameters  when  fits  are  applied  to  spectra  measured  in  the  commonly  used 
wavelength range of 500 to 1000 nm acquired with a silicon detector and the wavelength 
range  of  500  to  1600  nm  obtained  when  adding  an  InGaAs  spectrometer.  The  fitting 
procedure  was  deliberately  performed  without  constraining  the  values.  Judging  on  the 
confidence  intervals  computed  for  each  estimated  parameter,  having  an  additional 
spectrometer to measure up to 1600 nm provides up to four time higher confidence on the 
estimation  of  the  water  and  lipid  related  parameters  due  to  the  presence  of  additional 
absorption  features  above  1000  nm.  The  blood  volume  fraction  showed  a  factor  of  two 
improvement in the confidence intervals when fitting up to 1600 nm. The covariance between 
the reduced scattering amplitude and the water and lipid volume fraction is high for low 
reduced scattering amplitudes leading to errors in the estimation of absorbers if the fit is 
applied between 500 and 1000 nm. 
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